In The News: Department of Brain Health
Researchers looking for a pre-approved drug that can be reused to treat Alzheimer’s disease have found promising signs of efficacy in a 50-year-old generic drug commonly used as a diuretic.
Researchers say they hope to launch a clinical trial to test bumetanide, a diuretic approved in 2002, but how it might improve neural functioning is unclear.
A generic drug used widely to treat swelling associated with hypertension and heart failure showed hints in early research that it may also prevent the devastating brain damage of Alzheimer’s disease, a surprising twist that suggests scientists have a lot more to learn about the root cause of the neurodegenerative condition.
![KLAS-TV: 8 News Now](/sites/default/files/styles/100_width_25_height/public/news_source/logo/klas-tv.png?itok=ga_UNogP)
UNLV is leading the way towards an eventual cure for Alzheimer’s with groundbreaking research.
![KNPR News](/sites/default/files/styles/100_width_25_height/public/news_source/logo/knpr.png?itok=2vihM0TC)
Researchers at UNLV say they’ve strengthened the link between Type II diabetes and Alzheimer’s disease, which saps brain function and has no cure.
A team of neuroscientists from UNLV has confirmed the link between type 2 diabetes and Alzheimer's disease (AD) in a recent study published in the journal Communications Biology.
tudy shows chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory brain networks. The findings strengthen the link between type 2 diabetes and Alzheimer’s disease.
![U.S. News & World Report](/sites/default/files/styles/100_width_25_height/public/news_source/logo/us-news.png?itok=7bEsTGCG)
Type 2 diabetes may up the risk for Alzheimer's disease by altering brain function, new animal research suggests.
Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced the formation of a Scientific Advisory Board comprised of industry leaders in neurology and psychiatry, chaired by James E. Galvin, MD, MPH.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Diabetes turns out to be one of the factors in the development of Alzheimer's disease. One of the main features of diabetes - hyperglycemia - is responsible for alzheimer's-like changes.
A study by neuroscientists at the University of Nevada Las Vegas (UNLV) showed that chronic hyperglycemia also impairs memory.